TherapeuticsMD, Inc.
TXMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000025743
No open-market purchases or sales by TherapeuticsMD, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $8.10M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding TherapeuticsMD, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 155 | 2 | 150 | −3 |
| Shares | 171.5M | 13.8K | 132.6M | −38.8M (−22.6%) |
| Value | $203.9M | $16.0K | $98.2M | −$105.7M (−51.9%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held TherapeuticsMD, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 1,484,898 | $1.10M | 0.00% |
| Brandywine Global Investment Management, LLC | 1,018,900 | $755.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 473,232 | $351.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 167,163 | $124.0K | 0.00% |
| Barclays PLC | 162,003 | $121.0K | 0.00% |
| Two Sigma Advisers, LP | 153,301 | $114.0K | 0.00% |
| AQR Capital Management LLC | 81,838 | $61.0K | 0.00% |
| Natixis | 80,000 | $59.0K | 0.00% |
| Two Sigma Securities, LLC | 66,036 | $49.0K | 0.01% |
| Macquarie Group Ltd | 49,356 | $37.0K | 0.00% |
| Janus Henderson Group PLC | 37,660 | $28.0K | 0.00% |
| Point72 Hong Kong Ltd | 36,672 | $27.0K | 0.00% |
| Algert Global LLC | 25,455 | $19.0K | 0.00% |
| Two Sigma Investments, LP | 22,351 | $17.0K | 0.00% |
| Tobias Financial Advisors, Inc. | 16,000 | $12.0K | 0.00% |
| B. Riley Wealth Management, Inc. | 14,795 | $11.0K | 0.00% |
| Pictet Asset Management SA | 11,800 | $9.00K | 0.00% |
| Altium Wealth Management LLC | 10,000 | $7.00K | 0.00% |
| Parallax Volatility Advisers, L.P. | 2,600 | $2.00K | 0.00% |
| Ellevest, Inc. | 409 | $0 | 0.00% |
| Aspire Private Capital, LLC | 5 | $0 | 0.00% |
Sold out (24)
Institutions that held TherapeuticsMD, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Ra Capital Management, L.P. | 7,812,500 | $9.30M |
| AXA S.A. | 4,569,339 | $5.44M |
| Bamco Inc | 3,831,500 | $4.56M |
| Storebrand Asset Management AS | 2,862,873 | $3.41M |
| Laurion Capital Management LP | 785,325 | $935.0K |
| Sabby Management, LLC | 625,000 | $744.0K |
| Marshall Wace North America L.P. | 505,297 | $601.0K |
| Jupiter Asset Management Ltd | 338,923 | $403.0K |
| TD Asset Management Inc | 329,056 | $329.0K |
| Rafferty Asset Management, LLC | 89,658 | $107.0K |
| Virtu Financial LLC | 88,077 | $105.0K |
| Tectonic Advisors LLC | 85,000 | $101.0K |
| XTX Topco Ltd | 56,084 | $67.0K |
| Nisa Investment Advisors, LLC | 37,950 | $45.0K |
| ExodusPoint Capital Management, LP | 37,567 | $45.0K |
| HSBC Holdings PLC | 22,612 | $27.0K |
| Wolverine Trading, LLC | 23,073 | $27.0K |
| CIBC Asset Management Inc | 12,303 | $15.0K |
| Kestra Advisory Services, LLC | 11,556 | $14.0K |
| Founders Capital Management | 10,000 | $12.0K |
| The PNC Financial Services Group, Inc. | 2,175 | $3.00K |
| Trustcore Financial Services, LLC | 966 | $1.00K |
| Meeder Asset Management Inc | 1 | $0 |
| Red Door Wealth Management, LLC | 500 | $0 |
Not filed for Q3 2021 yet (2)
Institutions that held TherapeuticsMD, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 11,800 | $14.0K |
| CWM, LLC | 2,000 | $2.00K |